Results 201 to 210 of about 77,045 (328)

Optimizing Ultrasound‐Guided Placement of Cardiac Implantable Electronic Devices: Current Uses and Challenges

open access: yesEchocardiography, Volume 42, Issue 10, October 2025.
Cardiac implantable electronic devices (CIEDs) implantation using ultrasound has substantial benefits by providing real‐time visualization of veins, needles, guidewire positions, lead placement, and heart chambers. We discuss current limitations in ultrasound‐guided implantation, addressing visualization challenges, particularly in obese patients ...
Maham Bilal   +4 more
wiley   +1 more source

Distinctive Clinical Features of Portal Hypertension in Children with Portal Vein Thrombosis Following Liver Transplantation. [PDF]

open access: yesBiomedicines
Sansotta N   +7 more
europepmc   +1 more source

Long-Term Injection Sclerotherapy Treatment for Esophageal Varices

open access: green, 1989
J Terblanche   +2 more
openalex   +2 more sources

Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis.

open access: yesCochrane Database of Systematic Reviews, 2017
A. Colli   +6 more
semanticscholar   +1 more source

Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C

open access: yesJournal of Gastroenterology and Hepatology, Volume 40, Issue 10, Page 2568-2579, October 2025.
ABSTRACT Objective Hepatocellular carcinoma (HCC) can still occur in patients with chronic hepatitis C after achieving a sustained virologic response (SVR) with direct‐acting antiviral (DAA) therapy. Therefore, we aimed to identify and validate predictors and HCC risk models using longitudinal data.
Yu Rim Lee   +21 more
wiley   +1 more source

Hypertension as an Adverse Event Potentially Impacting the Therapeutic Efficacy of Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma

open access: yesJournal of Gastroenterology and Hepatology, Volume 40, Issue 10, Page 2580-2590, October 2025.
ABSTRACT Background and Aim Atezolizumab plus bevacizumab is used as a first‐line treatment for unresectable hepatocellular carcinoma (uHCC). However, the relationship between its adverse events (AEs) and treatment efficacy remains unclear. In this study, we aimed to clarify this association.
Kazuki Maesaka   +29 more
wiley   +1 more source

U‐Shaped Relationship Between CT‐Measured Liver‐To‐Spleen Volume Ratio and Mortality in HBV‐ACLF Patients

open access: yesJournal of Viral Hepatitis, Volume 32, Issue 10, October 2025.
ABSTRACT Hepatitis B virus‐related acute‐on‐chronic liver failure (HBV‐ACLF) is a life‐threatening condition with high short‐term mortality, making early prognosis crucial. The liver‐to‐spleen volume ratio (LSVR) provides important prognostic information but is not included in current tools.
Libo Yan   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy